Association between the ambulatory arterial stiffness index and the SCORE-derived vascular age in individuals without cardiovascular disease


KÖNTE H. C., ÇETİN M. S., ÖZCAN ÇETİN E. H., ARAS D.

Kardiologia Polska, cilt.84, sa.9, ss.1024-1031, 2026 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 84 Sayı: 9
  • Basım Tarihi: 2026
  • Doi Numarası: 10.33963/v.phj.113428
  • Dergi Adı: Kardiologia Polska
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Central & Eastern European Academic Source (CEEAS), CINAHL, EMBASE, Biomedical Reference Collection: Corporate Edition (EBSCO)
  • Sayfa Sayıları: ss.1024-1031
  • Anahtar Kelimeler: ambulatory arterial stiffness index, ambulatory blood pressure monitoring, arterial stiffness, biological age, vascular aging
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Background: The ambulatory arterial stiffness index (AASI), derived from ambulatory blood pressure monitoring, functions as a straightforward surrogate marker for arterial stiffness. Vascular age, calculated utilizing the SCORE (Systematic COronary Risk Evaluation) Project, has gained increasing prominence and accessibility as a tool for conveying cardiovascular (CV) risk and is progressively recognized as a surrogate marker for vascular biological aging. Aims: Our aim was to assess the association between the AASI and the SCORE-derived vascular age in individuals without established CV disease. Methods: In this cross-sectional study, 276 patients (53.6% women) aged 40–65 years without CV, cerebrovascular disease, or diabetes mellitus were evaluated. The AASI was calculated from 24-hour ambulatory blood pressure monitoring data, and vascular age was estimated using SCORE charts. The strength and independence of the association between the AASI and vascular age were evaluated using Pearson’s correlation and multivariable linear regression analyses. Results: The mean vascular age was 59.7 years and the mean AASI was 0.39. The AASI was significantly associated with vascular age (r = 0.529; P <0.001). In the multivariable analysis, a 0.1-unit increase in the AASI corresponded to a 0.992-year increase in vascular age (P = 0.015), independent of age, metabolic syndrome, and left ventricular mass. Conclusions: The AASI is significantly associated with the SCORE-derived vascular age, highlighting its potential utility as a simple, non-invasive indicator of vascular biological aging and a valuable tool for early CV risk stratification in outpatient settings.